ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) is a publicly traded company in the Unknown sector. Across all available filings, 56 corporate insiders have executed 435 transactions totaling $151.9M, demonstrating a bullish sentiment with $69.5M in net insider flow. The most recent transaction on Jun 28, 2024 involved a transaction of 70,055 shares valued at $1.0M.
No significant insider buying has been recorded for HRT in the recent period.
No significant insider selling has been recorded for HRT in the recent period.
Based on recent SEC filings, insider sentiment for HRT is bullish with an Insider Alignment Score of 73/100 and a net flow of $69.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 56 insiders are actively trading HRT stock, having executed 435 transactions in the past 90 days. The most active insider is James D. Carey (Executive), who has made 20 transactions totaling $28.2M.
Get notified when executives and directors at HRT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | P. Abramo Guy | Executive | Disposition | 70,055 | $14.35 | $1.0M | Large |
| Jun 28, 2024 | J. Blanton Laurie | Executive | Disposition | 17,479 | $14.35 | $250.8K | |
| Jun 28, 2024 | D. Carey James | Executive | Other | 18,463,397 | $N/A | $0 | |
| Jun 28, 2024 | D. Carey James | Executive | Disposition | 31,602 | $14.35 | $453.5K | |
| Jun 28, 2024 | William Copple Brian | Executive | Disposition | 21,403 | $14.35 | $307.1K | |
| Jun 28, 2024 | R. Daxner James | Executive | Disposition | 22,625 | $14.35 | $324.7K | |
| Jun 28, 2024 | F. Dzialga Mark | Executive | Disposition | 59,174 | $14.35 | $849.1K | Large |
| Jun 28, 2024 | E. Ensor Michael | Executive | Disposition | 14,829 | $14.35 | $212.8K | |
| Jun 28, 2024 | David Feldman Joshua | Executive | Disposition | 31,602 | $14.35 | $453.5K | |
| Jun 28, 2024 | M. Kern Rene | Executive | Disposition | 24,748 | $14.35 | $355.1K | |
| Jun 28, 2024 | M. Kutscher Lawrence | Executive | Disposition | 20,308 | $14.35 | $291.4K | |
| Jun 28, 2024 | Laplaine James | Executive | Disposition | 27,442 | $14.35 | $393.8K | |
| Jun 28, 2024 | R. Matthews James | Executive | Disposition | 31,602 | $14.35 | $453.5K | |
| Jun 28, 2024 | O'loughlin Mary | Executive | Disposition | 14,204 | $14.35 | $203.8K | |
| Jun 28, 2024 | M. Romero Julie | Executive | Disposition | 13,979 | $14.35 | $200.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 192 | $110.7M | 67.7% |
Sale(S) | 96 | $41.2M | 25.2% |
Disposition(D) | 24 | $9.7M | 5.9% |
Payment(F) | 24 | $1.7M | 1.0% |
Exercise (Options)(X) | 2 | $140.4K | 0.1% |
Award(A) | 20 | $97.6K | 0.1% |
Exercise(M) | 67 | $80.1K | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insiders at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ are accumulating shares at an accelerated pace. With 56 insiders making 435 transactions totaling $110.7M in purchases versus $41.2M in sales, the net buying activity of $69.5M signals strong executive confidence. James D. Carey (Executive) leads the buying activity with $28.2M in transactions across all time.